Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Zetterberg, Henrik"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 862
Tytuł:
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage.
Autorzy:
Tobieson L; Department of Neurosurgery in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. .
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Marklund N; Department of Neurosurgery in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Neurosurgery, Skåne University Hospital, Lund University, Lund, Sweden.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Aug 20; Vol. 11 (1), pp. 16950. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Axons/*pathology
Biomarkers/*blood
Biomarkers/*cerebrospinal fluid
Cerebral Hemorrhage/*blood
Cerebral Hemorrhage/*cerebrospinal fluid
Extracellular Fluid/*metabolism
Adult ; Aged ; Amyloid beta-Peptides/blood ; Amyloid beta-Peptides/cerebrospinal fluid ; Body Fluids/metabolism ; Brain/pathology ; Energy Metabolism ; Female ; Humans ; Male ; Middle Aged ; Neurofilament Proteins/blood ; Neurofilament Proteins/cerebrospinal fluid ; Time Factors ; tau Proteins/blood ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics.
Autorzy:
Gaetani L; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06100 Perugia, Italy.
Bellomo G; Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, 06100 Perugia, Italy.
Parnetti L; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06100 Perugia, Italy.; Laboratory of Clinical Neurochemistry, Department of Medicine and Surgery, University of Perugia, 06100 Perugia, Italy.
Blennow K; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 41 Mölndal, Sweden.
Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 41 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1E 6B, UK.
Di Filippo M; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06100 Perugia, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Jul 29; Vol. 10 (8). Date of Electronic Publication: 2021 Jul 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Machine Learning*
Proteomics*
Alzheimer Disease/*cerebrospinal fluid
Biomarkers/*cerebrospinal fluid
Inflammation/*cerebrospinal fluid
Aged ; Alzheimer Disease/diagnosis ; Alzheimer Disease/metabolism ; Cognitive Dysfunction ; Female ; Humans ; Inflammation/metabolism ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proteomic blood profiling in mild, severe and critical COVID-19 patients.
Autorzy:
Patel H; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. .; NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, De Crespigny Park, London, SE5 8AF, UK. .
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Psychiatry and Neurochemistry, Wallenberg Centre for Molecular and Translational Medicine, Institute of Neuroscience and Physiology, the SAHLGRENSKA Academy at the University of Gothenburg, Sahlgrenska University Hospital, MedTech West, Röda stråket 10B, 413 45, Göteborg, Sweden.; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK.
Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, De Crespigny Park, London, SE5 8AF, UK.; UK Dementia Research Institute at UCL, London, UK.; Health Data Research UK London, University College London, 222 Euston Road, London, UK.; Institute of Health Informatics, University College London, 222 Euston Road, London, UK.; The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, 222 Euston Road, London, UK.
Andersson LM; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Yilmaz A; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 18; Vol. 11 (1), pp. 6357. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Proteome*
Biomarkers/*blood
COVID-19/*blood
Central Nervous System Diseases/*virology
Aged ; COVID-19/complications ; Case-Control Studies ; Cohort Studies ; Female ; Gene Expression Profiling ; Gliosis/virology ; Humans ; Male ; Middle Aged ; Nerve Tissue Proteins/blood
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.
Autorzy:
Holmegaard L; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Stanne TM; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden.
Andreasson U; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Blomstrand C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jood K; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Jern C; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2021 Mar; Vol. 143 (3), pp. 303-312. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Atherosclerosis/*blood
Atherosclerosis/*complications
Biomarkers/*blood
Ischemic Stroke/*blood
Ischemic Stroke/*etiology
Adult ; Aged ; Arteries/pathology ; Female ; Humans ; Male ; Middle Aged ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics.
Autorzy:
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. henrik.zetterberg@clinchem.gu.se.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. henrik.zetterberg@clinchem.gu.se.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK. henrik.zetterberg@clinchem.gu.se.; UK Dementia Research Institute at UCL, London, UK. henrik.zetterberg@clinchem.gu.se.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden. .; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2021 Feb 19; Vol. 16 (1), pp. 10. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Alzheimer Disease/*diagnosis
Amyloid beta-Peptides/*cerebrospinal fluid
Biomarkers/*cerebrospinal fluid
Cognitive Dysfunction/cerebrospinal fluid ; Cognitive Dysfunction/diagnosis ; Humans ; Peptide Fragments/cerebrospinal fluid ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.
Autorzy:
Spotorno N; Department of Neurology, Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.; Department of Clinical Sciences, Clinical Memory Research Unit, Lund University, Malmö, Sweden.
Lindberg O; Division of Clinical Geriatrics, Karolinska Institute, Stockholm, Sweden.
Nilsson C; Division of Neurology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Landqvist Waldö M; Department of clinical Sciences, Clinical Sciences Helsingborg, Lund, Lund University, Lund, Sweden.
van Westen D; Department of Diagnostic Radiology, Clinical Sciences, Lund University, Lund, Sweden.
Nilsson K; Department of Clinical Sciences, Clinical Memory Research Unit, Lund University, Malmö, Sweden.
Vestberg S; Department of Psychology, Lund University, Lund, Sweden.
Englund E; Division of Pathology, Department of Clinical Sciences, Lund, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Lätt J; Center for Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden.
Markus N; Department of Diagnostic Radiology, Clinical Sciences, Lund University, Lund, Sweden.
Lars-Olof W; Division of Clinical Geriatrics, Karolinska Institute, Stockholm, Sweden.
Alexander S; Department of Clinical Sciences, Clinical Memory Research Unit, Lund University, Malmö, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Oct 27; Vol. 15 (10), pp. e0236384. Date of Electronic Publication: 2020 Oct 27 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Benchmarking*
Biomarkers/*blood
Diffusion Tensor Imaging/*methods
Frontotemporal Dementia/*pathology
Neurofilament Proteins/*blood
Aged ; Female ; Frontotemporal Dementia/blood ; Frontotemporal Dementia/diagnostic imaging ; Humans ; Longitudinal Studies ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
Autorzy:
Vallabh SM; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA. .; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA. .; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 415 Main St., Cambridge, MA, 02142, USA. .; Prion Alliance, Cambridge, MA, 02139, USA. .
Minikel EV; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 415 Main St., Cambridge, MA, 02142, USA.; Prion Alliance, Cambridge, MA, 02139, USA.
Williams VJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Carlyle BC; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
McManus AJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Wennick CD; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Bolling A; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Trombetta BA; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Urick D; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Nobuhara CK; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Gerber J; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Duddy H; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Lachmann I; AJ Roboscreen GmbH, 04129, Leipzig, Germany.
Stehmann C; Australian National CJD Registry, University of Melbourne, Parkville, 3010, Australia.
Collins SJ; Australian National CJD Registry, University of Melbourne, Parkville, 3010, Australia.
Blennow K; Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80, Mölndal, Sweden.; UK Dementia Research Institute, University College London, London, WC1N 3BG, UK.; Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N 3BG, UK.
Arnold SE; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA. .; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2020 Jun 18; Vol. 18 (1), pp. 140. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers/*metabolism
Neurodegenerative Diseases/*diagnosis
Prion Diseases/*diagnosis
Adult ; Cohort Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Neurodegenerative Diseases/blood ; Neurodegenerative Diseases/cerebrospinal fluid ; Prion Diseases/blood ; Prion Diseases/cerebrospinal fluid ; Reproducibility of Results ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
Autorzy:
Bader JM; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Geyer PE; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.; NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Müller JB; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Strauss MT; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Koch M; Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Leypoldt F; Institute of Clinical Chemistry, Faculty of Medicine, Kiel University, Kiel, Germany.; Department of Neurology, Faculty of Medicine, Kiel University, Kiel, Germany.
Koertvelyessy P; Department of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Bittner D; Department of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Schipke CG; Experimental & Clinical Research Center (ECRC), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, & Berlin Institute of Health, Berlin, Germany.
Incesoy EI; Department of Psychiatry, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin & Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany.
Peters O; Department of Psychiatry, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin & Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases, Berlin, Germany.
Deigendesch N; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Simons M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology, Munich, Germany.
Jensen MK; Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
Mann M; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.; NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Molecular systems biology [Mol Syst Biol] 2020 Jun; Vol. 16 (6), pp. e9356.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Proteomics*
Alzheimer Disease/*cerebrospinal fluid
Biomarkers/*cerebrospinal fluid
Proteome/*metabolism
Cohort Studies ; Glycolysis ; Humans ; Machine Learning ; Nerve Degeneration/pathology ; Neurons/metabolism ; Reproducibility of Results ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Autorzy:
Altmann P; Department of Neurology, Medical University of Vienna, Vienna, Austria.
De Simoni D; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria.
Kaider A; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Ludwig B; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Rath J; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Leutmezer F; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Zimprich F; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Hoeftberger R; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria.
Lunn MP; Neuroimmunology and CSF Laboratory, Institute of Neurology, University College London, London, UK.
Heslegrave A; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; The UK Dementia Research Institute at UCL, London, UK.
Berger T; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Zetterberg H; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; The UK Dementia Research Institute at UCL, London, UK.; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Institute of Neuroscience and Physiology, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Rommer PS; Department of Neurology, Medical University of Vienna, Vienna, Austria. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2020 Mar 17; Vol. 17 (1), pp. 86. Date of Electronic Publication: 2020 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers/*blood
Guillain-Barre Syndrome/*blood
Neurofilament Proteins/*blood
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Recovery of Function ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
Autorzy:
Colom-Cadena M; Centre for Discovery Brain Sciences, UK Dementia Research Institute at The University of Edinburgh, Edinburgh, UK.
Spires-Jones T; Centre for Discovery Brain Sciences, UK Dementia Research Institute at The University of Edinburgh, Edinburgh, UK.
Zetterberg H; Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Caggiano A; Cognition Therapeutics. Inc., Pittsburgh, PA, USA.
DeKosky ST; McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Fillit H; Alzheimer's Drug Discovery Foundation, New York, NY, USA.
Harrison JE; Metis Cognition Ltd, Kilmington, UK.; Alzheimer Center, AUmc, Amsterdam, The Netherlands.; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Schneider LS; Keck School of Medicine of USC, Los Angeles, CA, USA.
Scheltens P; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
de Haan W; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Clinical Neurophysiology and MEG, VU University Medical Center, Amsterdam, Netherlands.
Grundman M; Global R&D Partners, San Diego, CA, USA.
van Dyck CH; Alzheimer's Disease Research Unit and Departments of Psychiatry, Neurology, and Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Izzo NJ; Cognition Therapeutics. Inc., Pittsburgh, PA, USA.
Catalano SM; Cognition Therapeutics. Inc., Pittsburgh, PA, USA. .
Pokaż więcej
Corporate Authors:
Synaptic Health Endpoints Working Group
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Mar 02; Vol. 12 (1), pp. 21. Date of Electronic Publication: 2020 Mar 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Alzheimer Disease/*diagnostic imaging
Alzheimer Disease/*pathology
Biomarkers/*cerebrospinal fluid
Synapses/*pathology
Electroencephalography/methods ; Functional Neuroimaging/methods ; Humans ; Positron-Emission Tomography/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Repeated lumbar punctures within 3 days may affect CSF biomarker levels.
Autorzy:
Olsson M; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, House V, 431 80, Mölndal, Sweden. .; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden. .; Center for Sleep and Vigilance Disorders, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. .; Department of Anaesthesiology and Intensive Care Medicine, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden. .
Ärlig J; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, House V, 431 80, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Center for Sleep and Vigilance Disorders, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Hedner J; Center for Sleep and Vigilance Disorders, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.; Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, House V, 431 80, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.
Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, House V, 431 80, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Pokaż więcej
Źródło:
Fluids and barriers of the CNS [Fluids Barriers CNS] 2019 Dec 13; Vol. 16 (1), pp. 37. Date of Electronic Publication: 2019 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Biomarkers/*cerebrospinal fluid
Sleep Deprivation/*cerebrospinal fluid
Spinal Puncture/*adverse effects
Adult ; Alzheimer Disease/complications ; Female ; Humans ; Male ; Sleep Deprivation/complications ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
Autorzy:
DeMarshall C; Biomarker Discovery Center, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, United States of America.; Department of Geriatrics and Gerontology, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, United States of America.
Oh E; Department of Medicine, Psychiatry and Behavioral Sciences, Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States of America.
Kheirkhah R; Graduate School of Biomedical Sciences (GSBS), Rowan University, Stratford, New Jersey, United States of America.
Sieber F; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States of America.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, England, United Kingdom.; UK Dementia Research Institute at UCL, London, England, United Kingdom.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Nagele RG; Biomarker Discovery Center, New Jersey Institute for Successful Aging, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, United States of America.; Department of Geriatrics and Gerontology, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Nov 15; Vol. 14 (11), pp. e0225178. Date of Electronic Publication: 2019 Nov 15 (Print Publication: 2019).
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers*
Alzheimer Disease/*diagnosis
Alzheimer Disease/*etiology
Autoantibodies/*immunology
Aged ; Aged, 80 and over ; Alzheimer Disease/blood ; Alzheimer Disease/cerebrospinal fluid ; Autoantibodies/blood ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/etiology ; Female ; Hip Fractures/complications ; Hip Fractures/therapy ; Humans ; Male ; Protein Array Analysis ; Sensitivity and Specificity ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Autorzy:
Chatterjee P; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Goozee K; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.; KaRa Institute of Neurological Disease, Sydney, Macquarie Park, NSW, Australia.; Clinical Research Department, Anglicare, Sydney, Castle Hill, NSW, Australia.; School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, WA, Australia.
Lim CK; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.
Jacobs KR; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, King's College London, London, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia, South London and Maudsley NHS Foundation, London, UK.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Hye A; Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, King's College London, London, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia, South London and Maudsley NHS Foundation, London, UK.
Pedrini S; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.
Sohrabi HR; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.; KaRa Institute of Neurological Disease, Sydney, Macquarie Park, NSW, Australia.; Australian Alzheimer's Research Foundation, Nedlands, WA, Australia.
Shah T; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.; Australian Alzheimer's Research Foundation, Nedlands, WA, Australia.
Asih PR; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.
Dave P; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.; Clinical Research Department, Anglicare, Sydney, Castle Hill, NSW, Australia.
Shen K; Australian eHealth Research Centre, CSIRO, Floreat, WA, Australia.
Taddei K; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.; Australian Alzheimer's Research Foundation, Nedlands, WA, Australia.
Lovejoy DB; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.
Guillemin GJ; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Martins RN; Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, Australia. .; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia. .; KaRa Institute of Neurological Disease, Sydney, Macquarie Park, NSW, Australia. .; School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, WA, Australia. .; Australian Alzheimer's Research Foundation, Nedlands, WA, Australia. .; The Cooperative Research Centre for Mental Health, Carlton South, VIC, Australia. .; School of Medical and Health Sciences, Edith Cowan University, Ralph & Patricia Sarich Neuroscience Research Institute, 8 Verdun Street, Nedlands, WA, 6009, Australia. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2019 Oct 10; Vol. 16 (1), pp. 186. Date of Electronic Publication: 2019 Oct 10.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*blood
Amyloid beta-Peptides/*blood
Biomarkers/*blood
Kynurenine/*metabolism
Neurofilament Proteins/*blood
Aged ; Aged, 80 and over ; Female ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
Autorzy:
de Flon P; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Laurell K; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Sundström P; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Söderström L; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Gunnarsson M; Faculty of Medicine and Health, Department of Neurology, Örebro University, Örebro, Sweden.
Svenningsson A; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.; Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2019 May; Vol. 139 (5), pp. 462-468. Date of Electronic Publication: 2019 Mar 05.
Typ publikacji:
Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study
MeSH Terms:
Biomarkers/*analysis
Multiple Sclerosis, Relapsing-Remitting/*metabolism
Neurofilament Proteins/*metabolism
Adult ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunologic Factors/therapeutic use ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Neurofilament Proteins/analysis ; Rituximab/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Blood-based molecular biomarkers for Alzheimer's disease.
Autorzy:
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, he Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. henrik.zetterberg@clinchem.gu.se.; Clinical Neurochemistry Laboratory, Sahlgrenska, University Hospital, Mölndal, Sweden. henrik.zetterberg@clinchem.gu.se.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, UK. henrik.zetterberg@clinchem.gu.se.; UK Dementia Research Institute at UCL, London, UK. henrik.zetterberg@clinchem.gu.se.
Burnham SC; CSIRO Health and Biosecurity, Parkville, Victoria, 3052, Australia. .; Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, 6027, Australia. .
Pokaż więcej
Źródło:
Molecular brain [Mol Brain] 2019 Mar 28; Vol. 12 (1), pp. 26. Date of Electronic Publication: 2019 Mar 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Alzheimer Disease/*blood
Biomarkers/*blood
Exosomes/metabolism ; Humans ; Metabolomics ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Phenotype
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.
Autorzy:
Kam K; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Parekh A; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Sharma RA; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Andrade A; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Lewin M; Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, USA.
Castillo B; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Bubu OM; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Chua NJ; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Miller MD; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Mullins AE; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Glodzik L; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Mosconi L; Department of Neurology, Weill Cornell Medical College, New York, NY, USA.
Gosselin N; Center for Advanced Research in Sleep Medicine (CARSM), Department of Psychology, Hospital du Sacré-Coeur de Montreal, Montreal, Quebec, Canada and Université de Montreal, Montreal, Quebec, Canada.
Prathamesh K; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Chen Z; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Blennow K; Institute of Neuroscience and Psychiatry, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Institute of Neuroscience and Psychiatry, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Bagchi N; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Cavedoni B; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Rapoport DM; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
Ayappa I; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA.
de Leon MJ; Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, USA.
Petkova E; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.; Child and Adolescent Psychiatry, NYU School of Medicine, New York, NY, 10016, USA.
Varga AW; Mount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1232, New York, NY, 10029, USA. .
Osorio RS; Department of Psychiatry, NYU School of Medicine, New York, NY, 10016, USA. .; Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, USA. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2019 Feb 21; Vol. 14 (1), pp. 10. Date of Electronic Publication: 2019 Feb 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Amyloid beta-Peptides/*cerebrospinal fluid
Biomarkers/*cerebrospinal fluid
Peptide Fragments/*cerebrospinal fluid
Sleep/*physiology
tau Proteins/*cerebrospinal fluid
Aged ; Aged, 80 and over ; Alzheimer Disease/cerebrospinal fluid ; Female ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Polysomnography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
Autorzy:
Bos I; Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands. .; Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Universiteitssingel 40, Box 34, P.O. Box 616, 6200, MD, Maastricht, the Netherlands. .
Vos S; Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
Vandenberghe R; University Hospital Leuven, Leuven, Belgium.; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Scheltens P; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
Engelborghs S; Reference Center for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium.; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium.; University of Antwerp, Antwerp, Belgium.
Frisoni G; University of Geneva, Geneva, Switzerland.; IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Molinuevo JL; Alzheimer's Disease & Other Cognitive Disorders Unit, Hospital Clínic-IDIBAPS, Barcelona, Spain.; Barcelona Beta Brain Research Center, Fundació Pasqual Maragall, Barcelona, Spain.
Wallin A; Institute of Neuroscience and Physiology, Moelndal, Sweden.
Lleó A; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Popp J; Geriatric Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland.; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
Martinez-Lage P; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.
Baird A; University of Oxford, Oxford, UK.
Dobson R; King's College London, London, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK.; Farr Institute of Health Informatics Research, UCL Institute of Health Informatics, University College London, London, UK.; NIHR University College London Hospitals Biomedical Research Centre, London, UK.
Legido-Quigley C; King's College London, London, UK.
Sleegers K; Neurodegenerative Brain Diseases Group, VIB-Department of Molecular Genetics, Antwerp, Belgium.; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Van Broeckhoven C; Neurodegenerative Brain Diseases Group, VIB-Department of Molecular Genetics, Antwerp, Belgium.; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Bertram L; Lübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.; School of Public Health, Imperial College London, London, UK.; Department of Psychology, University of Oslo, Oslo, Norway.
Ten Kate M; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
Barkhof F; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Zetterberg H; Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute, London, UK.
Lovestone S; University of Oxford, Oxford, UK.
Streffer J; Experimental Medicine, Janssen Pharmaceutical Companies, Beerse, Belgium.
Visser PJ; Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2018 Jul 06; Vol. 10 (1), pp. 64. Date of Electronic Publication: 2018 Jul 06.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Research Design*
Alzheimer Disease/*blood
Biomarkers/*blood
Biomedical Research/*methods
Aged ; Aged, 80 and over ; Alzheimer Disease/diagnosis ; Amyloid beta-Peptides/blood ; Chitinase-3-Like Protein 1/blood ; Cognitive Dysfunction ; Cohort Studies ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neurofilament Proteins/blood ; Neurogranin/blood ; Neuropsychological Tests ; Psychiatric Status Rating Scales
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
Autorzy:
Lewczuk P; a Department of Psychiatry and Psychotherapy , Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg , Erlangen , Germany.; b Department of Neurodegeneration Diagnostics , Medical University of Białystok , and Department of Biochemical Diagnostics , University Hospital of Białystok , Białystok , Poland.
Riederer P; c Center of Mental Health, Clinic and Policlinic of Psychiatry, Psychosomatics and Psychotherapy , University Hospital Würzburg , Würzburg , Germany.
O'Bryant SE; d Institute for Healthy Aging , University of North Texas Health Science Center , Fort Worth , TX , USA.
Verbeek MM; e Department of Neurology , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Center , Nijmegen , The Netherlands.; f Department of Laboratory Medicine , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer center , Nijmegen , The Netherlands.
Dubois B; g Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Salpêtrièrie Hospital, INSERM UMR-S 975 (ICM), Paris 6 University , Paris , France.
Visser PJ; h Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience , Alzheimer Center Limburg, Maastricht University , Maastricht , The Netherlands.; i Department of Neurology , Alzheimer Centre, Amsterdam Neuroscience VU University Medical Centre , Amsterdam , The Netherlands.
Jellinger KA; j Institute of Clinical Neurobiology , Vienna , Austria.
Engelborghs S; k Reference Center for Biological Markers of Dementia (BIODEM) , University of Antwerp , Antwerp , Belgium.; l Department of Neurology and Memory Clinic , Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken , Antwerp , Belgium.
Ramirez A; m Department of Psychiatry and Psychotherapy , University of Bonn , Bonn , Germany.; n Institute of Human Genetics , University of Bonn , Bonn , Germany.; o Department of Psychiatry and Psychotherapy , University of Cologne , Cologne , Germany.
Parnetti L; p Section of Neurology, Center for Memory Disturbances, Lab of Clinical Neurochemistry , University of Perugia , Perugia , Italy.
Jack CR Jr; q Department of Radiology , Mayo Clinic , Rochester , MN , USA.
Teunissen CE; r Neurochemistry Lab and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience , VU University Medical Center Amsterdam , Amsterdam , The Netherlands.
Hampel H; s AXA Research Fund & UPMC Chair , Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France.
Lleó A; t Department of Neurology , Institut d'Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau, Universitat Autònoma de Barcelona , Barcelona , Spain.; u Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas , CIBERNED , Spain.
Jessen F; o Department of Psychiatry and Psychotherapy , University of Cologne , Cologne , Germany.; v German Center for Neurodegenerative Disorders (DZNE) , Bonn , Germany.
Glodzik L; w Center for Brain Health, Department of Psychiatry , NYU Langone Medical Center , New York , NY , USA.
de Leon MJ; w Center for Brain Health, Department of Psychiatry , NYU Langone Medical Center , New York , NY , USA.
Fagan AM; x Knight Alzheimer's Disease Research Center , Washington University School of Medicine , Saint Louis , MO , USA.; y Department of Neurology , Washington University School of Medicine , Saint Louis , MO , USA.
Molinuevo JL; z Barcelonabeta Brain Research Center , Pasqual Maragall Foundation , Barcelona , Spain.; aa Alzheimer's Disease and Other Cognitive Disorders Unit , Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona , Spain.
Jansen WJ; h Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience , Alzheimer Center Limburg, Maastricht University , Maastricht , The Netherlands.
Winblad B; ab Karolinska Institutet , Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics , Huddinge , Sweden.
Shaw LM; ac Department of Pathology and Laboratory Medicine, Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA , USA.
Andreasson U; ad Clinical Neurochemistry Laboratory , Sahlgrenska University Hospital , Mölndal , Sweden.; ae Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry , The Sahlgrenska Academy at the University of Gothenburg , Mölndal , Sweden.
Otto M; af Department of Neurology , University of Ulm , Ulm , Germany.
Mollenhauer B; ag Paracelsus-Elena-Klinik, Kassel and University Medical Center Göttingen, Department of Neurology , Göttingen , Germany.
Wiltfang J; ah Department of Psychiatry & Psychotherapy , University of Göttingen , Göttingen , Germany.; ai German Center for Neurodegenerative Diseases (DZNE) , Göttingen , Germany.; aj iBiMED, Medical Sciences Department , University of Aveiro , Aveiro , Portugal.
Turner MR; ak Nuffield Department of Clinical Neurosciences , University of Oxford , Oxford , UK.
Zerr I; ai German Center for Neurodegenerative Diseases (DZNE) , Göttingen , Germany.; al Clinical Dementia Centre, Department of Neurology , University Medical School , Göttingen , Germany.
Handels R; h Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience , Alzheimer Center Limburg, Maastricht University , Maastricht , The Netherlands.; ab Karolinska Institutet , Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics , Huddinge , Sweden.
Thompson AG; ak Nuffield Department of Clinical Neurosciences , University of Oxford , Oxford , UK.
Johansson G; ab Karolinska Institutet , Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics , Huddinge , Sweden.
Ermann N; a Department of Psychiatry and Psychotherapy , Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg , Erlangen , Germany.
Trojanowski JQ; ac Department of Pathology and Laboratory Medicine, Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA , USA.
Karaca I; m Department of Psychiatry and Psychotherapy , University of Bonn , Bonn , Germany.
Wagner H; m Department of Psychiatry and Psychotherapy , University of Bonn , Bonn , Germany.
Oeckl P; af Department of Neurology , University of Ulm , Ulm , Germany.
van Waalwijk van Doorn L; e Department of Neurology , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Center , Nijmegen , The Netherlands.; f Department of Laboratory Medicine , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer center , Nijmegen , The Netherlands.
Bjerke M; k Reference Center for Biological Markers of Dementia (BIODEM) , University of Antwerp , Antwerp , Belgium.
Kapogiannis D; am Laboratory of Neurosciences , National Institute on Aging/National Institutes of Health (NIA/NIH) , Baltimore , MD , USA.
Kuiperij HB; e Department of Neurology , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Center , Nijmegen , The Netherlands.; f Department of Laboratory Medicine , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer center , Nijmegen , The Netherlands.
Farotti L; p Section of Neurology, Center for Memory Disturbances, Lab of Clinical Neurochemistry , University of Perugia , Perugia , Italy.
Li Y; w Center for Brain Health, Department of Psychiatry , NYU Langone Medical Center , New York , NY , USA.
Gordon BA; x Knight Alzheimer's Disease Research Center , Washington University School of Medicine , Saint Louis , MO , USA.; an Department of Radiology , Washington University School of Medicine , Saint Louis , MO , USA.
Epelbaum S; g Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Salpêtrièrie Hospital, INSERM UMR-S 975 (ICM), Paris 6 University , Paris , France.
Vos SJB; h Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience , Alzheimer Center Limburg, Maastricht University , Maastricht , The Netherlands.
Klijn CJM; e Department of Neurology , Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Center , Nijmegen , The Netherlands.
Van Nostrand WE; ao Department of Neurosurgery, HSC T-12/086 , Stony Brook University , New York , NY , USA.
Minguillon C; z Barcelonabeta Brain Research Center , Pasqual Maragall Foundation , Barcelona , Spain.
Schmitz M; ai German Center for Neurodegenerative Diseases (DZNE) , Göttingen , Germany.; al Clinical Dementia Centre, Department of Neurology , University Medical School , Göttingen , Germany.
Gallo C; ap Departamento de Ciencias Celulares y Moleculares/Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía , Universidad Peruana Cayetano Heredia , Lima , Peru.
Lopez Mato A; aq Chair of Psychoneuroimmunoendocrinology , Maimonides University , Buenos Aires , Argentina.
Thibaut F; ar Department of Psychiatry , University Hospital Cochin-Site Tarnier 89 rue d'Assas, INSERM 894, Faculty of Medicine Paris Descartes , Paris , France.
Lista S; s AXA Research Fund & UPMC Chair , Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle Épinière (ICM), Département de Neurologie, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital , Paris , France.
Alcolea D; t Department of Neurology , Institut d'Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau, Universitat Autònoma de Barcelona , Barcelona , Spain.; u Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas , CIBERNED , Spain.
Zetterberg H; ad Clinical Neurochemistry Laboratory , Sahlgrenska University Hospital , Mölndal , Sweden.; ae Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry , The Sahlgrenska Academy at the University of Gothenburg , Mölndal , Sweden.; as Department of Molecular Neuroscience , UCL Institute of Neurology , London , UK.
Blennow K; ad Clinical Neurochemistry Laboratory , Sahlgrenska University Hospital , Mölndal , Sweden.
Kornhuber J; a Department of Psychiatry and Psychotherapy , Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg , Erlangen , Germany.
Pokaż więcej
Corporate Authors:
Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut
Źródło:
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2018 Jun; Vol. 19 (4), pp. 244-328. Date of Electronic Publication: 2017 Oct 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Biomarkers*/blood
Biomarkers*/cerebrospinal fluid
Consensus*
Biological Psychiatry/*standards
Dementia/*diagnosis
Neurodegenerative Diseases/*diagnosis
Societies, Medical/*standards
Dementia/blood ; Dementia/cerebrospinal fluid ; Humans ; Neurodegenerative Diseases/blood ; Neurodegenerative Diseases/cerebrospinal fluid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
Autorzy:
Novakova L; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Axelsson M; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Malmeström C; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Imberg H; Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.
Elias O; Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.
Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.
Nerman O; Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.
Lycke J; Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Apr 03; Vol. 13 (4), pp. e0194828. Date of Electronic Publication: 2018 Apr 03 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers*
Multiple Sclerosis/*diagnosis
Multiple Sclerosis/*metabolism
Neurons/*metabolism
Neurons/*pathology
Adolescent ; Adult ; Aged ; Brain/diagnostic imaging ; Brain/metabolism ; Brain/pathology ; Disease Progression ; Female ; Glial Fibrillary Acidic Protein ; Humans ; Macula Lutea/diagnostic imaging ; Macula Lutea/pathology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Models, Statistical ; Neurofilament Proteins/cerebrospinal fluid ; Organ Size ; Prognosis ; Recurrence ; Retinal Neurons/metabolism ; Retinal Neurons/pathology ; Tomography, Optical Coherence ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Autorzy:
Paterson RW; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Slattery CF; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Poole T; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Nicholas JM; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Magdalinou NK; Lila Weston Institute, UCL Institute of Neurology, London, UK.
Toombs J; Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Chapman MD; Department of Neuroimmunology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Lunn MP; Department of Neuroimmunology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Heslegrave AJ; Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Foiani MS; Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.
Weston PSJ; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Keshavan A; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Rohrer JD; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Rossor MN; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Warren JD; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Mummery CJ; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Fox NC; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Zetterberg H; Department of Molecular Neuroscience, Institute of Neurology, UCL, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Schott JM; Dementia Research Centre, UCL Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2018 Mar 20; Vol. 10 (1), pp. 32. Date of Electronic Publication: 2018 Mar 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diagnosis, Differential*
Alzheimer Disease/*cerebrospinal fluid
Alzheimer Disease/*diagnosis
Biomarkers/*cerebrospinal fluid
Aged ; Amyloid beta-Peptides/cerebrospinal fluid ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Phosphorylation ; ROC Curve ; Sensitivity and Specificity ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 862

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies